0577160 - ÚI 2024 RIV CZ eng J - Journal Article
Lukáš, M. - Hrubá, V. - Reissigová, Jindra - Černá, K. - Machková, N. - Ďuricová, D. - Kolář, M. - Vlková, K. - Čermáková, L. - Lukáš Jr., M.
Switch from biosimilar infliximab CT-P13 to biosimilar infliximab SB-2 in the long-term maintenance therapy in IBD patients – prospective observational study.
Gastroenterologie a hepatologie. Roč. 77, č. 4 (2023), s. 336-341. ISSN 1804-7874
Institutional support: RVO:67985807
Keywords : inflammatory bowel disease * biosimilar infliximab CT-P13 * biosimilar infliximab SB-2 * therapeutical switch
OECD category: Statistics and probability
Method of publishing: Limited access
Result website:
https://dx.doi.org/10.48095/ccgh2023336DOI: https://doi.org/10.48095/ccgh2023336
Permanent Link: https://hdl.handle.net/11104/0346393